Buy PT-141 Starter Kit in Australia
Buy PT-141 starter kit in Australia from Macropus Peptides: a PT-141 10mg vial with a 3 mL vial of bacteriostatic water, ten 0.5 mL insulin syringes and twenty alcohol swabs. PT-141, also called bremelanotide, is a cyclic seven amino acid melanocortin peptide derived from Melanotan II, and it is used to study the MC4R and MC3R receptors of the central nervous system. Dissolving the vial in the full 3 mL gives 3.33 mg per mL. Every vial is labelled with lot number and storage temperature, and a certificate of analysis for that lot is available on request. The kit costs roughly a fifth less than buying the vial, water, syringe pack and swab pack separately. A ready-made nasal spray is sold as well. Order online for dispatch from local Australian stock to any address in the country. For in-vitro laboratory research by buyers aged 18 and over only; not for human or veterinary use.
| Kit | PT-141 starter kit |
|---|---|
| Amount | starter kit |
| Form | Research kit |
| Contents | PT-141 10mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs |
| Category | Kits, stacks and value packs |
| Storage | See label |
| Testing | HPLC purity and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Buy PT-141 Starter Kit Australia: Bremelanotide 10mg Kit
This peptide targets melanocortin receptors in the brain rather than on pigment cells. A lab ordering it receives one 10mg vial plus water and consumables, and the lot printed on that vial links it to a certificate of analysis we issue on request. Groups comparing central and peripheral melanocortin signalling often order it beside the Melanotan II kit.
PT-141 kit supplies: what the box holds
Bremelanotide 10mg as powder, a 3 mL diluent vial, ten 0.5 mL syringes and twenty swabs.
PT-141 and bremelanotide: what the peptide is
It is a cyclic heptapeptide closely related to Melanotan II, differing mainly at its C-terminal end, and it acts chiefly at MC4R and MC3R, the melanocortin receptors of the hypothalamus. A 2006 review in Peptides followed how this family moved from pigment work into nervous system research, and Obstetrics and Gynecology published two phase 3 trials in 2019. The single vial is PT-141 10mg, and papers are in PT-141 research.
PT-141 water volume and concentration
- 3 mL: 3.33 mg per mL
- 2.5 mL: 4 mg per mL
- 2 mL: 5 mg per mL
These syringes read in insulin units; with a hundred to the millilitre, each line is a hundredth, and fifty lines make half a millilitre.
PT-141 kit price
| Option | Price |
|---|---|
| PT-141 starter kit | $118.99 |
The kit costs about a fifth less than assembling the bremelanotide vial and its consumables from separate listings.
PT-141 specifications
| Specification | Detail |
|---|---|
| Kit | PT-141 starter kit |
| Amount | starter kit |
| Form | Research kit |
| Contents | PT-141 10mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs |
| Category | Kits, stacks and value packs |
| Storage | See label |
Store the vial frozen and dark until use; once dissolved, keep it refrigerated. Consumables keep at room temperature.
Why buy PT-141 as a starter kit
Binding and signalling assays draw small, precise volumes over repeated sessions. The kit keeps the stock, its diluent and fine syringes on one lot record.
PT-141 kit or ready-made spray: which to order
The kit gives a vial you reconstitute to your own concentration. The PT-141 nasal spray arrives at 10mg in 10 mL for studies of that route.
Is PT-141 available in Australia
As a research peptide only. Bremelanotide has no ARTG registration in Australia, so we release it for in-vitro study.
Buy PT-141 online: melanocortin kits
Shipped from Australian stock to every state. The Melanotan II starter kit is the related kit, and all bundles are in kits and stacks.
References
- Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006.
- The cloning of a family of genes that encode the melanocortin receptors. Science. 1992.
- Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstetrics and Gynecology. 2019.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.